CREXONT
- Product NDC
- 64896-970
- 11-digit product format
- 648960970
- Labeler code
- 64896
- Product ID
- 64896-970_7ef8e64a-08b6-46d8-8b67-c8dfa7743ccc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbidopa and levodopa
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- NDA217186
- Marketing category
- NDA
- Marketing start
- 2024-08-09
- Substance
- CARBIDOPA HYDRATE; LEVODOPA
- Active strength
- 87.5; 350 mg/1; mg/1
- Pharmacologic classes
- Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CREXONT
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CARBIDOPA HYDRATE | 87.5 mg/1 |
| LEVODOPA | 350 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | MNX7R8C5VO, 46627O600J |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64896-970-16 | CREXONT | 1 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 1 | 18 | |
| 64896-970-16 | CREXONT | 120 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 120 | 18 | |
| 64896-970-23 | CREXONT | 120 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 120 | 18 | |
| 64896-970-23 | CREXONT | 1 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 1 | 18 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2690259 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690279 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690284 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690290 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | CREXONT 35 MG / 140 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | CREXONT 70 MG / 280 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690259 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690279 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690284 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690290 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690259 | carbidopa 35 MG / L-DOPA 140 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | carbidopa 35 MG / L-DOPA 140 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690279 | carbidopa 52.5 MG / L-DOPA 210 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | carbidopa 52.5 MG / L-DOPA 210 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690284 | carbidopa 70 MG / L-DOPA 280 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | carbidopa 70 MG / L-DOPA 280 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690290 | carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | Crexont (carbidopa 35 MG / levodopa 140 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | Crexont (carbidopa 52.5 MG / levodopa 210 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | Crexont (carbidopa 70 MG / levodopa 280 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | Crexont (carbidopa 87.5 MG / levodopa 350 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 64896-970-16 | 64896097016 | 1 BOTTLE in 1 CARTON (64896-970-16) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2024-08-09 | No | No | Current |
| 64896-970-23 | 64896097023 | 1 BOTTLE in 1 CARTON (64896-970-23) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2024-08-09 | Yes | No | Current |